clearwire

Following its bittersweet Q3, the latest financial report from Sprint this quarter offers up another mixed bag of news.

Sprint's Dan Hesse told us point-blank back in July that he was penning a "great story around 4G" for this fall, and it looks as if October 7th will be the date that it "al

It ain't as crazy as you may think.

The pool of choices for WiMAX hotspots continues to expand, and thanks to the FCC, we now know of another up-and-comer.

We'd figured that Sprint and partner Clearwire were going to have a devil of a time rolling out WiMAX this year in New York City; urban canyons are always tricky, of course, but their oddball 2500MHz spectrum allocation isn't the best at penetrating buildings and other structures, either.

You know what makes us happy?

Pizza. But a close second has to be 4G technology, which makes us truly envy the Bostonians who were treated to a sample of Verizon's trial LTE deployment in the friendly confines of a downtown pizza joint last month.

Looking at hundreds of FCC documents each and every week, it's pretty difficult for us to get too excited about any particular filing, but there are two words that do it for us each and every time: "LTE" and "WiMAX." In this case, the latter word caught our eye all throughout the filing for HTC model PC36100, which runs WiMAX on Sprin

Clearwire isn't the only American company building a carrier-independent (if you can call majority ownership by Sprint "carrier-independent") 4G network, you see -- and it would certainly behoove T-Mobile to investigate options that let it stay on a more GSM-aligned path for its next-gen network than WiMAX would, right?

The folks at ABI Research have done up a nice summary of the status of mobile WiMAX globally, saying that they expect the total number of subscribers to be at around two million come January.

Not every company has the design chops to make it in modern consumer electronics.

Case in point: NEC's Aterm WM3300R. While it looks like a thermostat you'd wall-mount at the local health center, it packs enough technological appeal to make up for that clinical dowdiness.